Physician

Anthony D Alfieri, D.O.

According to 2025 Medicare claims, Anthony Alfieri, D.O. (NPI: 1184604274) practices cardiology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from New Castle, DE. This provider's primary affiliated billing organization is ALFIERI CARDIOLOGY, P.A. (NPI: 1376583898; TIN: 204103485) and primary practice location at 19713-2059. Alfieri is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Alfieri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 897 traditional Medicare patients, billed 8,631 HCPCS/CPT codes, and received $697,454 in Medicare payments. The top billing code was 93970 (Ultrasound study of arm or leg veins with compression and maneuvers). Part D data shows 8,879 prescription claims across 1,037 beneficiaries totaling $2,738,402 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 261 claims. Open Payments data shows 145 records totaling $2,670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,063,703 and ending at $697,454. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $608,847 to $2,738,402. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $73,881 and ending at $32,164.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	771	4,458	$1,063,703
2016	822	5,539	$520,349
2017	787	5,254	$397,237
2018	737	5,364	$478,318
2019	863	4,898	$408,904
2020	1,269	11,584	$879,936
2021	1,219	11,751	$1,005,011
2022	1,099	10,233	$819,039
2023	986	10,235	$852,512
2024	897	8,631	$697,454

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	678	5,754	$608,847
2016	651	5,348	$764,006
2017	695	5,475	$982,250
2018	696	5,963	$1,250,992
2019	835	6,397	$1,948,329
2020	1,208	10,266	$2,583,793
2021	1,178	10,268	$2,966,136
2022	1,105	9,746	$3,780,667
2023	1,100	8,579	$3,314,471
2024	1,037	8,879	$2,738,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	238	575	$68,931
2016	201	430	$21,612
2017	253	630	$27,274
2018	259	644	$28,024
2019	244	559	$39,838
2020	239	667	$53,893
2021	208	500	$46,975
2022	178	428	$29,694
2023	95	279	$9,713
2024	80	261	$9,026

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93970	Ultrasound study of arm or leg veins with compression and maneuvers	219	234	$133
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	315	331	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	562	1,106	$86
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	411	3,678	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	404	562	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	407	29,405	$526,950
Xarelto	Rivaroxaban	351	23,291	$424,275
Entresto	Sacubitril/Valsartan	253	17,759	$388,686
Jardiance	Empagliflozin	195	13,441	$252,757
Mounjaro	Tirzepatide	162	6,150	$222,878

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	24	$1,897
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	14	39	$1,894
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	17	$1,489
A7031	Face mask interface, replacement for full face mask, each	N	N/R	15	$1,038
A7030	Full face mask used with positive airway pressure device, each	N	N/R	14	$965

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	145	$2,670	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony D. Alfieri, D.O.?

Tedicare shows public-source Medicare data for Anthony D. Alfieri, D.O. (NPI 1184604274), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony D. Alfieri, D.O. have ACO affiliation data?

Anthony D. Alfieri, D.O. is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Anthony D. Alfieri, D.O.?

Anthony D. Alfieri, D.O. is linked to ALFIERI CARDIOLOGY, P.A. (billing NPI 1376583898) in the available physician profile data.

Does Anthony D. Alfieri, D.O. have Open Payments data?

Anthony D. Alfieri, D.O. has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.